Literature DB >> 15998290

Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: possible role of increased norepinephrine turnover.

Yoko S Kaneko1, Keiji Mori, Akira Nakashima, Makoto Sawada, Ikuko Nagatsu, Akira Ota.   

Abstract

Cytokines and catecholamines are known to constitute a significant portion of the regulatory neuroimmune networks involved in maintaining homeostasis in the central nervous system (CNS). Although we have already reported an increase in norepinephrine (NE) turnover within the locus coeruleus (LC) at 2 and 4 h after the intraperitoneal (i.p.) injection of lipopolysaccharide (LPS), the implication of this increase remains unclear. In view of evidence that norepinephrine (NE) acts in an anti-inflammatory manner by way of negatively regulating pro-inflammatory cytokine expression, we examined the inflammatory cytokine expression levels in the LC of C3H/HeN mice (male, 8 weeks old) after an i.p. LPS injection. The mRNA expression levels of the genes encoding IL-1beta and TNF-alpha within the LC increased during the first 2 h, and showed two peaks, the first at 4 h and the second lesser one at 15 h after the LPS injection. Microglia, which are one of the major cell types that produce pro-inflammatory cytokines in the CNS, were isolated from mouse neonate brains in order to clarify more precisely the relationship between the changes in NE content and the up-regulation of inflammatory cytokines in the LC. Simultaneous incubation of microglia with LPS and NE enhanced the expression of IL-1beta at both mRNA and protein levels, but reduced the mRNA and protein levels of TNF-alpha. These data support the hypothesis that NE negatively regulates the expression of pro-inflammatory cytokine expression, at least in the case of TNF-alpha, which action could contribute to the observed anti-inflammatory properties of NE. This report, based on the results of both in vivo and in vitro experiments, is the first to suggest a relationship between NE content and cytokine expression levels in the CNS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998290     DOI: 10.1111/j.1471-4159.2005.03209.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced Neuroinflammation in BV2 Microglia and a Mouse Model.

Authors:  Min Sung Gee; Sang-Won Kim; Namkwon Kim; Soo Jin Lee; Myung Sook Oh; Hee Kyung Jin; Jae-Sung Bae; Kyung-Soo Inn; Nam-Jung Kim; Jong Kil Lee
Journal:  Neurochem Res       Date:  2018-10-16       Impact factor: 3.996

2.  Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice.

Authors:  Ann-Charlotte Granholm; Vandana Zaman; Jennifer Godbee; Michael Smith; Riad Ramadan; Claudia Umphlet; Patrick Randall; Narayan R Bhat; Baerbel Rohrer; Lawrence D Middaugh; Heather A Boger
Journal:  Brain Pathol       Date:  2010-12-08       Impact factor: 6.508

3.  Expression and regulation in the brain of the chemokine CCL27 gene locus.

Authors:  Chad Gunsolly; James D Nicholson; Samuel J Listwak; Dolena Ledee; Peggy Zelenka; Daniela Verthelyi; Svetlana Chapoval; Achsah Keegan; Leonardo H Tonelli
Journal:  J Neuroimmunol       Date:  2010-06-03       Impact factor: 3.478

4.  Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.

Authors:  Flávia V Santa-Cecília; Benjamin Socias; Mohand O Ouidja; Julia E Sepulveda-Diaz; Leonardo Acuña; Rangel L Silva; Patrick P Michel; Elaine Del-Bel; Thiago M Cunha; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2016-01-08       Impact factor: 3.911

5.  Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G₁ phase and protects them from UV light-induced apoptosis.

Authors:  Yoko S Kaneko; Akira Ota; Akira Nakashima; Hiroshi Nagasaki; Yu Kodani; Keiji Mori; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2014-06-12       Impact factor: 3.575

6.  Receptor and transporter binding and activity profiles of albiflorin extracted from Radix paeoniae Alba.

Authors:  Zeng-Liang Jin; Nana Gao; Weizhe Xu; Pingxiang Xu; Shuaiqi Li; Yuan-Yuan Zheng; Ming Xue
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

7.  Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.

Authors:  David J Braun; Sergey Kalinin; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2017 Mar-Apr       Impact factor: 4.146

8.  Role of catalpol in ameliorating the pathogenesis of experimental autoimmune encephalomyelitis by increasing the level of noradrenaline in the locus coeruleus.

Authors:  Qian Li; Tao Yang; An-Chen Guo; Yong-Ping Fan
Journal:  Mol Med Rep       Date:  2018-01-05       Impact factor: 2.952

9.  Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.

Authors:  Elisa Schmidt; Christian Schinke; Michael Rullmann; Julia Luthardt; Georg-Alexander Becker; Sarah Haars; Muriel Stoppe; Donald Lobsien; Karl-Titus Hoffmann; Osama Sabri; Swen Hesse; Florian Then Bergh
Journal:  Sci Rep       Date:  2020-09-04       Impact factor: 4.379

10.  COL-3, a chemically modified tetracycline, inhibits lipopolysaccharide-induced microglia activation and cytokine expression in the brain.

Authors:  Rawan Abdulhameed Edan; Yunus A Luqmani; Willias Masocha
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.